with Prof. Eric Lim, Prof. Kenji Suzuki, Prof. Yasuhiro Tsutani
For many years, lobectomy has been considered the gold standard oncologic resection for non-small cell lung cancer (NSCLC). However, as technology advances and a deeper understanding of segmental anatomy, segmentectomy has gained attention as a viable alternative. This less invasive option has shown promising results, although the oncologic equivalency between these techniques still remains under investigation. This event will bring together the two perspectives on this critical topic. On one hand, one of the pioneering countries of the practice and adoption of segmentectomy, Japan. On the other hand, the defending viewpoint of lobectomy over segmentectomy from a leading expert in Europe.
PROGRAM
Clinical Background
Welcome & Introduction - Prof. Kenji Suzuki (Japan)
Indications for Intentional Segmentectomy for Lung Cancer - A European Perspective - Prof. Eric Lim (UK)
Indications for Intentional Segmentectomy for Lung Cancer from the Japanese Perspective - Prof. Yasuhiro Tsutani (Japan)
Q&A Session - All faculty moderated by Prof. Kenji Suzuki (Japan)
Closing Remarks - Prof. Kenji Suzuki (Japan)
Share it with your network and help spread clinical knowledge.
